PBMs Looking Beyond Traditional Rebate Model In Selling Medicare Part D
Executive Summary
Pharmacy benefit management companies are not focusing on the traditional rebate model as a cost-saving mechanism in their Medicare prescription drug plans
You may also be interested in...
Pfizer Medicare Part D Formulary Placement: Bundled Up, Or Out In The Cold?
Pfizer appears to have taken an all-or-nothing approach to negotiating formulary positioning for its products in Medicare Part D prescription drug plans, according to an analysis by "The Pink Sheet" of plan formularies
Pfizer Medicare Part D Formulary Placement: Bundled Up, Or Out In The Cold?
Pfizer appears to have taken an all-or-nothing approach to negotiating formulary positioning for its products in Medicare Part D prescription drug plans, according to an analysis by "The Pink Sheet" of plan formularies
Medco Anticipates $2 Bil. Boost From Medicare In 2006
Medco expects its retiree drug spend to increase by 22% to $11.2 bil. in 2006, thanks to the Medicare drug benefit, company officials said during the pharmacy benefit manager's Nov. 10 analyst day in New York